NeuroSense Therapeutics Ltd. (NRSNW) Financials
NRSNW Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2025 | 1.0 million | 2.6 million |
| Sept. 30, 2025 | 1.0 million | 2.6 million |
| June 30, 2025 | 1.7 million | 2.2 million |
| March 31, 2025 | 1.7 million | 2.2 million |
NRSNW Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2025 | -1.8 million | 917000 |
| Sept. 30, 2025 | -1.8 million | 917000 |
| June 30, 2025 | -2000 | 153 |
| March 31, 2025 | -2000 | 153 |
NRSNW Net Income
No data available :(
NRSNW Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2025 | 166000 | - | 170000 |
| Sept. 30, 2025 | 166000 | - | 170000 |
| June 30, 2025 | 666000 | - | - |
| March 31, 2025 | 666000 | - | - |
NRSNW Shares Outstanding
NRSNW Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2025 | 1500 | 1.9 million | 1.3 million | - |
| Sept. 30, 2025 | 1500 | 1.9 million | 1.3 million | - |
| June 30, 2025 | - | 1.3 million | 1.1 million | - |
| March 31, 2025 | - | 1.3 million | 1.1 million | - |
NRSNW Cost of Revenue
No data available :(
NRSNW
Price: $0.01
52 week price:
Earnings Per Share: -0.94 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 3227
Market Capitalization: 986667